Monday, July 28, 2025 11:29:56 AM
In my opinion, Nasrat checks all the boxes.
If he had not bought half of the Adderall with Mikah, the company would not be functioning today, or we would have 2 plus billion shares.
-----------------------------------------
v A CEO's fiduciary duty is a legal obligation to act in the best interests of the company and its shareholders. This duty encompasses several key components: loyalty, care, and good faith. Essentially, a CEO must prioritize the company's well-being over their own and act with diligence, honesty, and transparency in all corporate matters.
Key aspects of a CEO's fiduciary duty:
Duty of Care:
.
v This requires the CEO to make informed decisions, acting with the same level of diligence and prudence that a reasonable person would in a similar situation. This includes being well-informed about the company's operations, considering all relevant information before making decisions, and avoiding negligence or recklessness.
Duty of Loyalty:
v This means the CEO must act in the best interests of the company and its shareholders, putting their needs above their own. This includes avoiding conflicts of interest, not using company resources for personal gain, and not taking advantage of corporate opportunities for personal benefit.
Duty of Good Faith:
.
v This duty requires the CEO to act honestly, fairly, and with integrity in all corporate dealings. It also includes a duty of obedience, requiring the CEO to act within the bounds of the law and the company's governing documents.
If he had not bought half of the Adderall with Mikah, the company would not be functioning today, or we would have 2 plus billion shares.
-----------------------------------------
v A CEO's fiduciary duty is a legal obligation to act in the best interests of the company and its shareholders. This duty encompasses several key components: loyalty, care, and good faith. Essentially, a CEO must prioritize the company's well-being over their own and act with diligence, honesty, and transparency in all corporate matters.
Key aspects of a CEO's fiduciary duty:
Duty of Care:
.
v This requires the CEO to make informed decisions, acting with the same level of diligence and prudence that a reasonable person would in a similar situation. This includes being well-informed about the company's operations, considering all relevant information before making decisions, and avoiding negligence or recklessness.
Duty of Loyalty:
v This means the CEO must act in the best interests of the company and its shareholders, putting their needs above their own. This includes avoiding conflicts of interest, not using company resources for personal gain, and not taking advantage of corporate opportunities for personal benefit.
Duty of Good Faith:
.
v This duty requires the CEO to act honestly, fairly, and with integrity in all corporate dealings. It also includes a duty of obedience, requiring the CEO to act within the bounds of the law and the company's governing documents.
-----------------------------------------------------------------------------------------------
I believe in Elite, and its CEO Nasrat Hakim - This is why I am long !!!
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
